retatrutide mechanism of action triple agonist glp-1 gip glucagon The power three: Retatrutide's role in modern obesity and diabetes therapy Retatrutide vs. Ozempic: The Triple

Glucagon-like peptide-1 is secreted from L-cells of the gut into the bloodstream

Kulldorff, M

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Aldawsari M, Almadani FA, Almuhammadi N, Algabsani S, Alamro Y, Aldhwayan M

Rapid Employer Adoption of GLP-1 Coverage as a Hedge Against Long-Term Healthcare Costs A 2024 Employee Benefit Research Institute analysis found that self-insured employers covering semaglutide or tirzepatide cut diabetes-related claims by 12% and cardiovascular hospitalizations by 9% within 18 months, offsetting annual drug costs in the USD 12,00016,000 range

61 However, only one of the five studies included in the meta-analysis was a randomised controlled study